Business Standard

Nifty view and stock calls by Anand Rathi: Buy Glenmark Pharma, MPhasis

Glenmark Pharma's stock is taking the support of a rising trend line

Equity fund managers buy Infosys, sell Reliance Industries in October
Premium

Mphasis' stock has provided a breakout from a bullish pennant pattern on the daily chart

Nilesh Jain Mumbai
BUY NIFTY | TARGET: 11,320 | STOP LOSS: 11,100

The Nifty index continued to make a higher top and higher bottom formation on the daily chart and recently, it has taken the support of its 200-DMA which is placed at 10,860. So, as long as it trades above its 200-DMA, the overall setup looks positive. The momentum indicators and oscillators on the weekly scales are still in buy mode which hints at some buying at lower levels. The volatility index is currently near 23 levels which hints of no major movement in the short term. Thus, short term trader can initiate

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in